Full-Time

Pharmacy Supervisor

Posted on 12/13/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$115k - $191.7k/yr

Rochester, MN, USA

In Person

Willing to travel up to 5% of the time (within state and out of state).

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Graduate of an accredited school of pharmacy.
  • Current, active Pharmacy license as granted by the State Board of Pharmacy.
  • At least 3 to 5 years of experience in a clean room or infusion pharmacy setting OR 2 years of experience and one of the following: (a) knowledge of non-sterile compounding, and MTM (b) completion of an ASHP accredited Pharmacy Residency Program, or (c) equivalent experience as approved by the VP of Pharmacy and/or SVP of Clinical Services.
  • Willingness to travel up to 5% of the time for business purposes (within state and out of state).
Responsibilities
  • Delivers and manages appropriate patient care. Determines suitability of patients for home care. Assesses patients' suitability for home care in accordance with Option Care policies.
  • Directs the daily activities of the pharmacy department so that they reflect a priority on the delivery of pharmaceutical care. Arranges work activities so that the pharmaceutical-care needs of patients are met.
  • Oversees the state and federal regulatory requirements set forth to operate an alternate site pharmacy. May act as the pharmacist in charge per state regulation. Assists the director of pharmacy with ensuring that all state and federal pharmacy and controlled substance licensure requirements are current and valid.
  • Ensures all appropriate staff is trained to effectively use computers and admixture devices to increase efficiency in performing practice responsibilities and observes legal and ethical guidelines for safeguarding the confidentiality of patient and proprietary Option Care information.
  • Provides support to sales professionals and general manager by speaking knowledgeably of the scope of services that are available through Option Care. Description of available services is accurate. Meets with managed care organizations and other accounts to facilitate education regarding available services.
  • Oversees the purchase, management and security of all medications, pumps and medical supplies in accordance with the Option Care policies and formulary guidelines.
  • Designs, recommends, monitors and evaluates patient-specific pharmacy care plans for the pharmacotherapy of home care patients.
  • Modifies the pharmacy care plans for home care patients based on evaluation of monitoring data and other pertinent patient-specific information. Competent in use of pharmacokinetic principles and formulas. Competent in assessing patient laboratory values.
  • Ensures that medications are prepared and dispensed using appropriate techniques and following Option Care’ policies and procedures. Equipment is accurately calibrated.
  • Provides in-service education to physicians, nurses, pharmacy technicians, and other practitioners on home care pharmacy-related issues. Designs effective educational programs for physicians, nurses, pharmacy technicians, and other practitioners on home care pharmacy-related issues.
  • Manages and utilizes pharmacy staff and supports personnel effectively. Prioritizes the workload and organizes the workflow, taking into account available resources.
  • Coordinates and participates in on-call responsibilities of the pharmacy department.
Desired Qualifications
  • Post-graduate program in clinical pharmacy service.
  • Required certification from the Board in Nutrition Support Pharmacy, Pharmacotherapy or other clinical pharmacy practice area.
  • At least 1 year of experience managing inventory and logistics.
  • Active member of a state or national professional organization.
  • At least 3 years of experience compounding sterile products and managing complex infusion patients.
  • At least 1 year of experience overseeing purchasing and inventory process of all pharmaceutical and related substances and supplies.

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Analyst price targets up to $40.09 suggest 46% upside from May levels.
  • Expanded $850M credit facility enables M&A consolidation in fragmented market.
  • Management projects $7B revenue by 2029 assuming CID reset normalizes.

What critics are saying

  • Chronic Inflammatory Disease portfolio headwind of $55M persists beyond 2026.
  • Revenue growth slowed to 1.1% versus historical 12% and industry 4.7%.
  • Biosimilar conversions and IRA headwinds compress margins $25–35M annually through 2027.

What makes Option Care Health unique

  • Largest independent home infusion provider with 315,000+ unique patients served.
  • 40% of claims processed without human intervention via automation investments.
  • Diversified portfolio across acute, chronic, and immunoglobulin neurology therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE